93
Participants
Start Date
July 31, 2011
Primary Completion Date
February 29, 2012
Study Completion Date
June 30, 2012
Placebo
Intravenous placebo monthly during treatment phase.
Statin
Single daily dose of atorvastatin (40 or 80 mg), rosuvastatin (20 or 40 mg) or simvastatin (40 or 80 mg) from Day 1 to Day 141/ET.
PF-04950615 (RN316)
Intravenous 10mg/mL based on weight monthly during treatment phase.
Statin
Single daily dose of atorvastatin (40 or 80 mg), rosuvastatin (20 or 40 mg) or simvastatin (40 or 80 mg) from Day 1 to Day 141/ET.
PF-04950615 (RN316)
Intravenous 10mg/mL based on weight monthly during treatment phase.
Statin
Single daily dose of atorvastatin (40 or 80 mg), rosuvastatin (20 or 40 mg) or simvastatin (40 or 80 mg) from Day 1 to Day 141/ET.
PF-04950615 (RN316)
Intravenous 10mg/mL based on weight monthly during treatment phase.
Satin
Single daily dose of atorvastatin (40 or 80 mg), rosuvastatin (20 or 40 mg) or simvastatin (40 or 80 mg) from Day 1 to Day 141/ET.
PF-04950615 (RN316)
Intravenous 10mg/mL based on weight monthly during treatment phase.
Statin
Single daily dose of atorvastatin (40 or 80 mg), rosuvastatin (20 or 40 mg) or simvastatin (40 or 80 mg) from Day 1 to Day 141/ET.
Altoona Center for Clinical Research, Duncansville
Perelman Center for Advanced Medicine, Philadelphia
Translational Research Center, Philadelphia
National Clinical Research - Richmond, Inc., Richmond
National Clinical Research - Norfolk, Inc., Norfolk
North Carolina Clinical Research, Raleigh
PMG Research of Salisbury, Salisbury
Spartanburg Medical Research, Spartanburg
North Georgia Clinical Research, Woodstock
North Georgia Internal Medicine, Woodstock
Jacksonville Center for Clinical Research, Jacksonville
Avail Clinical Research, LLC, DeLand
In Vivo Clinical Research, Inc., Doral
Kendall South Medical Center, Miami
Innovative Research of West Florida, Inc., Clearwater
New Orleans Center for Clinical Research, Knoxville
Volunteer Research Group, Knoxville
L-MARC Research Center, Louisville
Commonwealth Biomedical Research, LLC, Madisonville
Medex Healthcare Research, Inc., St Louis
Saint Luke's Hospital, Kansas City
Saint Luke's Lipid and Diabetes Research Center, Kansas City
The Center for Pharmaceutical Research, P.C., Kansas City
Vince and Associates Clinical Research, Overland Park
Heartland Research Associates, LLC, Wichita
Lynn Health Science Institute, Oklahoma City
Oklahoma Cardiovascular Research Group (OCRG), Oklahoma City
Oklahoma Heart Hospital Physicians, Oklahoma City
Oklahoma Heart Hospital, Oklahoma City
Texas Center for Drug Development, Inc., Houston
Paragon Research Center, LLC, San Antonio
Clinical Trials of Texas, Inc., San Antonio
San Antonio Preventive & Diagnostic Medicine, PA, San Antonio
New Mexico Clinical Research & Osteoporosis Center, Incorporated, Albuquerque
Orange County Research Center, Tustin
Diablo Clinical Research, Inc., Walnut Creek
Maine Research Associates, Auburn
Infinity Medical Research, North Dartmouth
The Medical Arts Health Research Group, Kelowna
Q & T Research Chicoutimi, Chicoutimi
Centre de Recherche Clinique de Laval, Laval
Diex Research Montreal Inc., Montreal
Clinique des Maladies Lipidiques de Quebec Inc., Québec
Diex Research Sherbrooke Inc., Sherbrooke
Lead Sponsor
Pfizer
INDUSTRY